デフォルト表紙
市場調査レポート
商品コード
1331047

経鼻ドラッグデリバリーの世界市場

Intranasal Drug Delivery

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 459 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
経鼻ドラッグデリバリーの世界市場
出版日: 2023年08月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 459 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

経鼻ドラッグデリバリーの世界市場は2030年までに926億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に555億米ドルと予測された経鼻ドラッグデリバリーの世界市場は、2030年までに926億米ドルの市場規模に改定され、分析期間2022-2030年のCAGR6.6%で成長すると予測されます。本レポートで分析したセグメントの1つである液体送達デバイスは、CAGR 6.2%を記録し、分析期間終了までに380億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、粉末デリバリー機器セグメントの成長は今後8年間のCAGRを7.5%に修正しました。

米国市場は232億米ドル、中国はCAGR 8.9%で成長すると予測

米国の経鼻ドラッグデリバリー市場は、2022年には232億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 8.9%で推移し、2030年までに81億米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ5.2%と5.4%の成長が予測されています。欧州では、ドイツがCAGR約6.3%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋市場は、2030年までに73億米ドルに達すると予測されています。

調査対象企業の例

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1795

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Intranasal Drug Delivery Market to Reach $92.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Intranasal Drug Delivery estimated at US$55.5 Billion in the year 2022, is projected to reach a revised size of US$92.6 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2022-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$38 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Powder Delivery Devices segment is readjusted to a revised 7.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $23.2 Billion, While China is Forecast to Grow at 8.9% CAGR

The Intranasal Drug Delivery market in the U.S. is estimated at US$23.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.3 Billion by the year 2030.

Select Competitors (Total 77 Featured) -

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Promising Intranasal Vaccines to Nip COVID-19 Virus at Point of Entry
    • Rapid Progress despite Roadblocks
    • Nasal Sprays for Protection against COVID-19 Infection
    • Influencer Market Insights
    • World Market Trajectories
    • Intranasal Drug Delivery - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Intranasal Drug Delivery: A Prelude
    • Leading Indications and APIs Amenable to Nasal Drug Delivery
    • Regional Market Analysis
    • Why Nasal Application is Garnering Notable Attention for Drug Delivery
    • Limitations of Intranasal Drug Delivery
    • Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range
    • Drug Delivery Pathways Related to the Nasal Cavity
    • Systemic delivery and Local Delivery Routes
    • Differences between Systemic Delivery and Local Effects
    • Challenges Involved In Formulating Nasal Drugs
    • Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
    • Nose-to-Brain Drug Delivery: An Evolving Area of Interest
    • Factors Inhibiting Nose-to-Brain Transportation of Drugs
    • Bioavailability: An Important Facet of Intranasal Drug Delivery
    • Traditional Vs. Advanced Intranasal Drug Formulation Types
    • Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application
    • Select FDA-Approved Nasal Products Compound (Trade Name) Indication Dosage Form Year
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Prevalence of COPD Drives Opportunities
    • Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
    • Pharmaceutical and Medical Device Companies Vie to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
    • Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
    • The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
    • The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
    • Intranasal Corticosteroids : A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
    • Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage
    • Manufacturers Focus on Improved Nasal Delivery Platforms
    • Controlled Release Technology is the Buzz Word
    • Research on Nanocarrier-Based Intranasal Drug Delivery Systems Picks Up Pace
    • Potential Role in Treatment and Management of Coronavirus Infection
    • Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
    • Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
    • Top Nasal Inhalers, Sprays, and Drops Brands in the US (2019): Percentage Share Breakdown of Dollar Sales
    • Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
    • Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
    • Intranasal Therapeutics Delivery: A High Potential Method for Treating CNS Diseases
    • Researchers Develop Nasal Spray Treatment for Parkinson's Disease
    • Future Opportunities in CNS Space
    • Intranasal Delivery of Stem Cells: A Primary Strategy for Treatment of CNS Disorders
    • Intranasal Delivery of Stem Cells: Limitations
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Intranasal Delivery of Peptide-Based Pharmaceuticals
    • Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace
    • Select List of Nasal Biologics Available in the Market
    • Benefits of Bi-Directional Nasal Drug Delivery
    • Rise in Interest in Preservative-free Nasal Spray Formulations
    • Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Appendix: List of Select Intranasal Drugs in Phase III Clinical Trials
    • List of Select Intranasal Drugs for Pain Management in Phase III Clinical Trials
    • Select Intranasal Drugs for Cancer in Phase III Clinical Trials
    • Select Intranasal Drugs for Diabetes in Phase III Clinical Trials
    • Select Intranasal Drugs for Nasal Polyps in Phase III Clinical Trials
    • Select Intranasal Drugs for Depression in Phase III Clinical Trials
    • Select Intranasal Drugs for Chronic Sinusitis in Phase III Clinical Trials
    • Select Intranasal Drugs for Migraine in Phase III Clinical Trials
    • Intranasal Drugs for Allergic Rhinitis in Phase III Clinical Trials
    • Select Intranasal Drugs for Diabetes Mellitus in Phase III Clinical Trials
    • Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials
    • Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 3: World 14-Year Perspective for Liquid Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 6: World 14-Year Perspective for Powder Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 9: World 14-Year Perspective for Pressurized Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 12: World 14-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 15: World 14-Year Perspective for Respiratory Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 18: World 14-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 21: World 14-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 24: World 14-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2023 & 2030
    • TABLE 25: World Intranasal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2016 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 28: World 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 31: USA 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 34: USA 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 37: Canada 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 40: Canada 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • JAPAN
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 43: Japan 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 46: Japan 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • CHINA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 49: China 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 52: China 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • EUROPE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 55: Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 58: Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 61: Europe 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2023 & 2030
  • FRANCE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 64: France 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 67: France 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • GERMANY
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 70: Germany 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 73: Germany 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 76: Italy 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 79: Italy 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • UNITED KINGDOM
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 82: UK 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 85: UK 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 88: Spain 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 91: Spain 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 94: Russia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 97: Russia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 103: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • ASIA-PACIFIC
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2023 & 2030
  • AUSTRALIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 115: Australia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 118: Australia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • INDIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 121: India 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 124: India 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 127: South Korea 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 130: South Korea 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • LATIN AMERICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 139: Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 142: Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 145: Latin America 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2023 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 148: Argentina 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 151: Argentina 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 154: Brazil 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 157: Brazil 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 160: Mexico 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 163: Mexico 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 166: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 169: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • MIDDLE EAST
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 172: Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 175: Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 178: Middle East 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2023 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 181: Iran 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 184: Iran 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 187: Israel 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 190: Israel 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 193: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 196: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 199: UAE 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 202: UAE 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 205: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 208: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030
  • AFRICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 211: Africa 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2023 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2021 and % CAGR
    • TABLE 214: Africa 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2023 & 2030

IV. COMPETITION